Stobbe Group strategy

Stobbe Group is the umbrella for 2 Swiss mother companies with Danish subsidiaries all operating in a league of its own. The management of Stobbe Group coordinate the research, development, manufacturing, sales, services. And supply pharmaceutical industry end-users, contractors, and Process-Control-System (PCS) suppliers with ground-breaking technologies.

Cellmembra Mini With SUSCellmembra Range Summer 2016D3C 21953 Liter Magnetic Drive DetailErato Ready To Rock And Roll Incl ThoraxCellmembra Medium With SUP And CFFLachesis 1 And Pumps For Cellmembra 3 Size

Stobbe Group are continuously looking for ways to improve services and processes. Feedback from our internal audits, customer audits, and project reviews help identifying opportunities for improvement. Put simple - it means ‘getting better all the time’.

Stobbe Group has one owner (shareholder), no investors, no bank loans, no bank credit, no dept - and as to such Stobbe Group are simple to collaborate with and highly trustworthy. This based on the simple wish that through our better technologies we will all benefit from reduced medical product end-user prices. Since 2007 the impressive investment in the Stobbe Group portfolio reached >32 mio Euro. We believe in our own and our kids future.